Treatment of cerebellar ataxia with buspirone: A double-blind study [18]

Lancet

Volumn 348, Issue 9029, 1996, Pages 759-

  Trouillas, P ^a   Xie, J ^a   Adeleine, P ^a  

^a HÔPITAL NEUROLOGIQUE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BUSPIRONE; SEROTONIN 1A AGONIST;

CEREBELLAR ATAXIA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; HYPERSOMNIA; INSOMNIA; LETTER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; VERTIGO;

EID: 0029779627     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)65674-7     Document Type: Letter

References (5)

1. V Chan-Palay Indoleamine neurons and their processes in the normal rat brain and in chronic diet-induced thiamine deficiency, demonstrated by 3H-serotonin J Comp Neurol 176 1979 467 494
2. P Trouillas F Brudon P Adeleine Improvement of cerebrovascular ataxia with levorotatary form of 5-hydroxytryptophan: a double-blind study with quantified data processing Arch Neurol 45 1988 1217 1222
3. JS Lou L Goldfarb L McShane P Gatev M Hallett Use of buspirone for treatment of cerebellar ataxia: an open-label study Arch Neurol 52 1995 462 468
4. 1A, sur l'ataxie cérébelleuse: une étude pilote Rev Neurol 12 1995 708 713
5. P Trouillas The serotonergic hypothesis of cerebellar ataxia and its pharmacological consequences P Trouillas K Fuxe Serotonin, the cerebellum and ataxia 1993 Raven Press New York 323 334